266 related articles for article (PubMed ID: 32964395)
1. Laron syndrome - A historical perspective.
Laron Z; Werner H
Rev Endocr Metab Disord; 2021 Mar; 22(1):31-41. PubMed ID: 32964395
[TBL] [Abstract][Full Text] [Related]
2. Fifty seven years of follow-up of the Israeli cohort of Laron Syndrome patients-From discovery to treatment.
Laron Z; Kauli R
Growth Horm IGF Res; 2016 Jun; 28():53-6. PubMed ID: 26307357
[TBL] [Abstract][Full Text] [Related]
3. A half-century of studies of growth hormone insensitivity/Laron syndrome: A historical perspective.
Rosenbloom AL
Growth Horm IGF Res; 2016 Jun; 28():46-50. PubMed ID: 26276451
[TBL] [Abstract][Full Text] [Related]
4. Novel growth hormone receptor mutation in a Chinese patient with Laron syndrome.
Hui HN; Metherell LA; Ng KL; Savage MO; Camacho-Hübner C; Clark AJ
J Pediatr Endocrinol Metab; 2005 Feb; 18(2):209-13. PubMed ID: 15751611
[TBL] [Abstract][Full Text] [Related]
5. Clinical and Molecular Features of Laron Syndrome, A Genetic Disorder Protecting from Cancer.
Janecka A; Kołodziej-Rzepa M; Biesaga B
In Vivo; 2016; 30(4):375-81. PubMed ID: 27381597
[TBL] [Abstract][Full Text] [Related]
6. LESSONS FROM 50 YEARS OF STUDY OF LARON SYNDROME.
Laron Z
Endocr Pract; 2015 Dec; 21(12):1395-402. PubMed ID: 26401581
[TBL] [Abstract][Full Text] [Related]
7. IGF-I deficiency, longevity and cancer protection of patients with Laron syndrome.
Laron Z; Kauli R; Lapkina L; Werner H
Mutat Res Rev Mutat Res; 2017; 772():123-133. PubMed ID: 28528685
[TBL] [Abstract][Full Text] [Related]
8. Novel growth hormone receptor gene mutation in a patient with Laron syndrome.
Arman A; Yüksel B; Coker A; Sarioz O; Temiz F; Topaloglu AK
J Pediatr Endocrinol Metab; 2010 Apr; 23(4):407-14. PubMed ID: 20583548
[TBL] [Abstract][Full Text] [Related]
9. Clinical features and growth hormone receptor gene mutations of patients with Laron syndrome from a Chinese family.
Ying YQ; Wei H; Cao LZ; Lu JJ; Luo XP
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Aug; 9(4):335-8. PubMed ID: 17706034
[TBL] [Abstract][Full Text] [Related]
10. Primary growth hormone (GH) insensitivity and insulin-like growth factor deficiency caused by novel compound heterozygous mutations of the GH receptor gene: genetic and functional studies of simple and compound heterozygous states.
Fang P; Riedl S; Amselem S; Pratt KL; Little BM; Haeusler G; Hwa V; Frisch H; Rosenfeld RG
J Clin Endocrinol Metab; 2007 Jun; 92(6):2223-31. PubMed ID: 17405847
[TBL] [Abstract][Full Text] [Related]
11. The first homozygous mutation (S226I) in the highly-conserved WSXWS-like motif of the GH receptor causing Laron syndrome: supression of GH secretion by GnRH analogue therapy not restored by dihydrotestosterone administration.
Jorge AA; Souza SC; Arnhold IJ; Mendonca BB
Clin Endocrinol (Oxf); 2004 Jan; 60(1):36-40. PubMed ID: 14678285
[TBL] [Abstract][Full Text] [Related]
12. Insights from the clinical phenotype of subjects with Laron syndrome in Ecuador.
Guevara-Aguirre J; Bautista C; Torres C; Peña G; Guevara C; Palacios C; Guevara A; Gavilanes AWD
Rev Endocr Metab Disord; 2021 Mar; 22(1):59-70. PubMed ID: 33047268
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone receptor-deficient pigs resemble the pathophysiology of human Laron syndrome and reveal altered activation of signaling cascades in the liver.
Hinrichs A; Kessler B; Kurome M; Blutke A; Kemter E; Bernau M; Scholz AM; Rathkolb B; Renner S; Bultmann S; Leonhardt H; de Angelis MH; Nagashima H; Hoeflich A; Blum WF; Bidlingmaier M; Wanke R; Dahlhoff M; Wolf E
Mol Metab; 2018 May; 11():113-128. PubMed ID: 29678421
[TBL] [Abstract][Full Text] [Related]
14. Effects of heterozygosity for the E180 splice mutation causing growth hormone receptor deficiency in Ecuador on IGF-I, IGFBP-3, and stature.
Guevara-Aguirre J; Rosenbloom AL; Guevara-Aguirre M; Yariz K; Saavedra J; Baumbach L; Shuster J
Growth Horm IGF Res; 2007 Jun; 17(3):261-4. PubMed ID: 17350302
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone insensitivity syndrome caused by a heterozygous GHR mutation: phenotypic variability owing to moderation by nonsense-mediated decay.
Gorbenko del Blanco D; de Graaff LC; Visser TJ; Hokken-Koelega AC
Clin Endocrinol (Oxf); 2012 May; 76(5):706-12. PubMed ID: 22117696
[TBL] [Abstract][Full Text] [Related]
16. Identification of a novel mutation in the human growth hormone receptor gene (GHR) in a patient with Laron syndrome.
Gennero I; Edouard T; Rashad M; Bieth E; Conte-Aurio F; Marin F; Tauber M; Salles JP; El Kholy M
J Pediatr Endocrinol Metab; 2007 Jul; 20(7):825-31. PubMed ID: 17849745
[TBL] [Abstract][Full Text] [Related]
17. Novel splice site mutation in the growth hormone receptor gene in Turkish patients with Laron-type dwarfism.
Arman A; Ozon A; Isguven PS; Coker A; Peker I; Yordam N
J Pediatr Endocrinol Metab; 2008 Jan; 21(1):47-58. PubMed ID: 18404972
[TBL] [Abstract][Full Text] [Related]
18. Clinical, Endocrine, and Molecular Genetic Analysis of a Large Cohort of Saudi Arabian Patients with Laron Syndrome.
Al-Ashwal AA; Al-Sagheir A; Ramzan K; Al-Owain M; Allam R; Qari A; Al-Numair NS; Imtiaz F
Horm Res Paediatr; 2017; 88(2):119-126. PubMed ID: 28743110
[TBL] [Abstract][Full Text] [Related]
19. Growth Hormone Receptor Mutations Related to Individual Dwarfism.
Lin S; Li C; Li C; Zhang X
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29748515
[TBL] [Abstract][Full Text] [Related]
20. Obese adults with primary growth hormone resistance (Laron Syndrome) have normal endothelial function.
Shechter M; Ginsberg S; Scheinowitz M; Feinberg MS; Laron Z
Growth Horm IGF Res; 2007 Apr; 17(2):165-70. PubMed ID: 17320443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]